Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/HALOZYME-THERAPEUTICS-INC-50245/news/Halozyme-Therapeutics-Announces-First-Clinical-Dosing-Of-Adalimumab-Humira-Using-ENHANZE-Tech-21723778/?utm_source=whatsapp&utm_medium=social&utm_campaign=share